TikTok Content Creators Driving Unofficial Market for Unapproved Slimming Medication

An underground market for unlicensed slimming medications is propelled by TikTok fitness influencers and vendors on communication apps, based on new investigations.

Experimental Treatment Acquiring Traction Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its supposed fat-burning effects. Followers are urged to message these profiles privately for source information, while also obtaining discount codes.

Thriving Trade on Social Networks

Additionally, a robust market exists on messaging services, where groups with thousands of members share “before and after” images, injection guides and assertions of rapid British shipping. Sellers market the drug there before redirecting customers to other platforms for transactions.

Understanding Retatrutide

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Medical Experts Voice Concerns

Nevertheless, physicians and chemists have cautions that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to users injecting substances of uncertain source.

Several experts stated the popularity for retatrutide could be linked to the rising price of licensed slimming treatments such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved medication that must not be marketed or supplied for human use under the British medical regulations.

Some content creators attempt to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still breach medicines, advertising, and consumer regulations, potentially leading to fines, legal action or prison.

Platform Response and Material Removal

According to TikTok, the service has taken down problematic content and prohibited related keywords and query recommendations. The company said it was dedicated to keeping the service secure and investing in enhancing compliance measures.

Digital Marketplace Activities

Research also found communities with up to 9,000 members selling retatrutide using the platform's built-in search feature, which functions like a online catalog. Typing “retatrutide” instantly displays groups with thousands of members, filled with photos of slimming results, positive testimonials and detailed instructions for mixing or administering at home.

Within minutes of entering one community, a seller shared WhatsApp details, where most transactions take place. The seller sent an guidebook and guaranteed shipping within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about weight, medical conditions or previous experience.

Product Information and Pricing

Inside these communities, messages display dark colored parcels with Royal Mail labels, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use pens typically priced at £160 for 20 milligrams. When asked how much time a injector should be used, vendors give conflicting answers varying between a several days to “depends on your body”.

Platform Oversight and Security Measures

A representative for the messaging service stated it regularly moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are injecting materials they can’t verify. Although the research behind this drug is sound, these digital products may not include what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor linked the surge in demand to current cost increases for approved weight-loss medications such as Mounjaro. “With costs increasing, patients are turning to online platforms. But fake treatments are extremely risky. You cannot know what’s inside or whether the environment they were made in was clean,” she said.

Her team has previously seen patients harmed by self-injection from unconfirmed sources. “We understand the frustration, but buying from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can market [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a Lilly experimental substance not yet approved … may expose users to potentially serious medical dangers”.

Angel Ferguson
Angel Ferguson

A seasoned journalist with over a decade of experience covering UK politics and current affairs, known for insightful analysis and engaging storytelling.